Huang et al. analyze matched adults with obesity receiving Tirzepatide, Semaglutide, Phentermine/Topiramate, Naltrexone/Bupropion, or Phentermine monotherapy. Iirzepatide mirrors semaglutide for ocular safety, while both drugs link to fewer cataracts, oculomotor dysfunction, and visual issues than phentermine or naltrexone/bupropion.
- Yu-Nan Huang
- Jo-Ching Chen
- Pen-Hua Su